T remulous voice is a characteristic feature of a multitude of movement disorders, including essential tremor, orofacial dystonia, spasmodic dysphonia, Parkinson's disease (PD), and progressive supranuclear palsy, as well as other neurological diseases including stroke and myasthenia gravis. Perhaps one of the clearest associations exists between tremulous voice and essential tremor. Tremulous voice occurring in individuals diagnosed with essential tremor is referred to as essential vocal tremor (EVT).
T remulous voice is a characteristic feature of a multitude of movement disorders, including essential tremor, orofacial dystonia, spasmodic dysphonia, Parkinson's disease (PD), and progressive supranuclear palsy, as well as other neurological diseases including stroke and myasthenia gravis. Perhaps one of the clearest associations exists between tremulous voice and essential tremor. Tremulous voice occurring in individuals diagnosed with essential tremor is referred to as essential vocal tremor (EVT). 1 It has been estimated that up to 40% of individuals diagnosed with essential tremor also present with an EVT. 48 In EVT, laryngeal, pharyngeal, and/or palatal muscles rhythmically oscillate at a rate of 4-8 Hz, resulting in alterations in pitch and/or loudness of the voice. 1 Perceptions of alterations in pitch and loudness correlate with acoustic modulations of fundamental frequency (F0) and intensity, respectively. Vocal symptoms of EVT are present across the majority of phonatory activities but are most prominent during sustained phonation of vowels. 1, 26 Although there appears to be substantial interspeaker variability in the regularity and intensity of F0 and amplitude modulations, individuals with EVT consistently report an increase in vocal effort that significantly worsens with anxiety and stress. 18, 26 The devastating impact of EVT on quality of life should not be ignored. For individuals with EVT, their tremulous voice is associated with significant social embarrassment and in severe cases may result in the discontinuation of employment and hobbies.
Tremulous voice is a symptom of laryngeal tremor, a multifaceted disorder characterized by both intralaryngeal and extralaryngeal movement. 48 During laryngeal tremor, involuntary contraction of antagonistic skeletal muscles leads to an oscillatory movement of the laryngeal apparatus. Rhythmic contraction of intrinsic laryngeal muscles such as the thyroarytenoid and lateral and posterior cricoarytenoid muscles, extrinsic laryngeal muscles, pharyngeal muscles, and palatal muscles gives rise to a tremulous voice. 26 Tremulous voice may further be affected by involuntary contraction of accessory muscles used for voice production, including the diaphragm and muscles of the chest wall and abdomen.
Assessment and treatment of evt
EVT is typically evaluated through the combined efforts of an otolaryngologist specializing in assessment and treatment of voice disorders and a speech language pathologist. Current recommendations dictate that clinical identification, quantification, and characterization of EVT be conducted using a sustained phonatory vowel task during fiberoptic nasolaryngoscopic examination of pharyngeal and laryngeal musculature supplemented with acoustic measures. 11 Transnasal endoscopy is preferred to oral endoscopy because it permits thorough evaluation of the pharynx and larynx in a more natural posture. 18 During transnasal endoscopy, rhythmic oscillatory motion of the vocal folds is considered diagnostic for laryngeal tremor. 26 This is frequently accompanied by contractions of the palate and pharynx and/or oscillations of the larynx in a craniocaudal direction. Tremor may be observed during both quiet respiration and sustained vowel phonation.
It is critical that direct laryngeal examination be supplemented with acoustic measures. Acoustic evaluation of EVT is best performed using sustained phonation of vowels as tremor may be partially masked during connected speech.
1 EVT is described acoustically by the rate of the F0 and intensity modulation. 24 Typically, modulations in F0 tend to co-occur with intensity modulations. 1 EVT may also be described by the magnitude of F0 and intensity modulation. Magnitude is evaluated by measuring the range of F0 and intensity oscillations. Additional instrumental measures of voice have included acoustic analysis of perturbation measures such as jitter, shimmer, and harmonic-to-noise ratio. Elevated jitter and shimmer and decreased harmonic-to-noise ratio are typical instrumental voice findings in patients with EVT. 7 Historically, management of EVT has been extremely difficult.
1 First-line treatment is medical, and propranolol and primidone have been used with variable results. 18 A number of patients with EVT have also been treated with botulinum A toxin (Botox) injections into the thryroarytenoid muscle. However, in this instance, improved symptoms are dependent on a tremor that primarily involves the thryroarytenoid muscle. More recently, there have been reports that a subset of patients with EVT may benefit from behavioral intervention with a speech language pathologist.
dbs for evt
Overall, current behavioral and medical interventions for vocal tremor result in suboptimal outcomes. DBS has been characterized as a potential therapeutic avenue for approximately 15 years, but, to date, few studies can be identified that have systematically examined improvements in EVT following DBS. The first published case reports of DBS specifically for the treatment of vocal tremor were by Sataloff et al. in 2002 . 40 Two patients underwent bilateral stimulator implantation in the ventral intermediate nucleus (Vim) and were evaluated by strobovideolaryngoscopy and objective voice analysis, with elimination of voice tremor in one patient and significant decrease in the other. 40 Additional studies exist for vocal tremor but are either case reports or include data from a limited number of participants. 4, 28, 49 Reductions in voice tremor have also been reported following DBS for patients with varied pathologies including essential hand tremor, 4 PD-associated tremor, 42 and dystonia. 12 Reductions in voice tremor were an ancillary result of DBS targeting the thalamus and associated thalamic nuclei. Voice tremor reduction did not mirror in magnitude the improvement seen in other areas of tremor. 4, 12, 28, 42 Similar results have been seen in DBS for PD, where traditional stimulation of the subthalamic nucleus (STN) and medication have demonstrated varied and inconsistent effects of improvement in voice tremor and vocalization. 35, 36, 39, 43, 46 Here, we present a case of awake, bilateral DBS targeting the Vim in a patient suffering from severe voice and arm tremor. To our knowledge, this is the first time comprehensive intraoperative voice evaluation has been used to guide microelectrode/stimulator placement, as well as the first time that standard pre-and post-DBS voice assessments have been conducted, demonstrating the efficacy of this tailored DBS approach.
vim target for dbs
The usefulness of the Vim as an electrical stimulation target for the treatment of tremor was first discovered by Benabid et al. in 1987. 3 As a conglomeration of the cerebellar afferents, the Vim has a strictly somatotopic organization, with the face occurring medially, followed by the hands and legs from medial to lateral (Fig. 1) . 14, 16, 25 The Vim is difficult to distinguish on MRI, and, as a result, stereotactic referencing is required for indirect targeting. 21, 37 Additionally, intraoperative physiological mapping with microelectrode recording is often necessary. 2 The location of the Vim nucleus varies by individual, but is targeted approximately 12-14 mm lateral to the anterior commissure-posterior commissure (AC-PC) line and 6 mm posterior to the midpoint of the AC-PC. 32 We target the Vim directly. As the microelectrode passes caudally along its course toward the Vim, activation of units begins to occur more with passive kinesthetic movement of extremity joints. 27 Given that the somatotopic map of the thalamus has the receptive fields of the face medial, upper extremity ventromedial, and lower extremity dorsolateral, the standard dorsolateral-to-ventromedial track into the Vim encounters first leg and then arm passive kinesthetic receptive fields. The ventrooralis anterior and ventrooralis posterior nuclei are found just anterior to Vim where voluntary movements of the contralateral extremities drive tonic activity. 22 The ventral caudalis nucleus is signaled by cutaneous receptive fields activated by very light touch in a narrow somatotopic region that distinguishes it from the Vim posteriorly. 13, 25 Precise definition of the border of the Vim with the ventral caudalis can assist in accurate electrode implantation a safe distance (> 2 mm) from the ventral caudalis nucleus. 2 The typical target for implantation of the DBS electrode for essential tremor is within the kin-esthetic fields corresponding to the hand. Within the target Vim zone, microelectrode stimulation with currents up to 100 mA and macroelectrode stimulation with currents as low as 0.2 mA should achieve complete or near-complete tremor suppression. 2, 8 Sensations of paresthesias elicited proximal to the ventral caudalis nucleus will distinguish within 10 seconds if stimulated from the Vim; thus, tremor suppression in the absence of sustained paresthesia is the goal during stimulation.
case report
This 57-year-old woman had a lifelong history of essential tremor that worsened 7 years prior to presentation. She was started on propranolol, which initially relieved her symptoms. However, as her tremor progressed, she began to have voice tremor in addition to bilateral arm tremor that interfered with her activities of daily living and profession as a notary. On physical examination, the patient was noted to have tremor present throughout her body at rest and a quivering voice present at all times during conversation. Her tremor was approximately 3-5 Hz and of low amplitude, greater on the right side of her body than the left. The tremor was present at rest but exacerbated with any kind of reaching motion or with lifting of the lower extremities, consistent with the diagnosis of essential tremor. The rest of her neurological examination was unremarkable.
The patient was referred to a laryngologist (C.K.S.) who performed a preoperative flexible distal-chip laryngosco- The patient was subsequently taken to the operating room for implantation of bilateral Vim DBS electrodes via a frameless approach with intraoperative microelectrode recording and electrophysiology. Given the medial-to-lateral facial-forelimb-hindlimb somatotopy of the thalamic motor nuclei, targets were chosen approximately 1-2 mm medial to the typical target for essential tremor to suppress voice tremor. 44, 45 The left Vim nucleus was targeted approximately 13 mm lateral to the AC-PC line and 6 mm posterior to the midpoint of the AC-PC. The right Vim nucleus was targeted approximately 12 mm lateral to the AC-PC line and 6 mm posterior to the midpoint of the AC-PC. Standard intraoperative microelectrode recording with electrophysiology was performed as well as detailed intraoperative voice function assessment (E.E.D.) during placement of the microelectrode (Tables 1 and 2 ).
In the first microelectrode pass, kinesthetic responses were encountered at the foot and the arm as we approached the Vim. These responses registered with passive range of motion of the foot 10-12 mm above target to the arm roughly 4-7 mm above target. There were kinesthetic responses to tongue movement from 3.6 mm above target to 1.1 mm above target. Along this depth there was also some kinesthetic response to upper-extremity passive range of movement. The base of the thalamus was encountered at 1 mm below target. Macrostimulation through the cannula was performed at a depth of 7 mm above target from 0.2 to 3 mA increasing in 0.2-mA increments. The impedance was 0.47. There were no clear paresthesias up to 3 mA and no involvement of the internal capsule. Her speech was less dysarthric, and there was some mild improvement in postural and action tremor, but tremor did not completely resolve at higher currents. Macrostimulation through the cannula at the target depth revealed paresthesias at 0.2 mA that was experienced over the entire right side of her body and into the right face. Therefore, a second pass was performed 2 mm anterior to the first pass. Microelectrode recording was similar but demonstrated a quieter background than the previous track. Macrostimulation was performed through the cannula at 10 mm above the target, at 5 mm above the target, and at the target depth. At 10 mm above target there was no evidence of adverse sensory or motor effects with some reduction but no resolution in tremor. At 5 mm above target, a similar pattern was found. At the target depth there was a threshold for paresthesias of 0.5 mA, and clear tremor improvement at 1 mA both in the postural position and with action without any adverse effects. Her speech was tested, and results revealed some mild improvement even with cannula stimulation at 2 mA. The paresthesias resolved within 5 seconds. With this excellent result, the deep brain stimulating lead was implanted along this track. The base of Contact 0 was placed at 0 mm of the target depth. Macrostimulation was performed in a monopolar mode through Contacts 0 through 3. Monopolar stimulation through Contact 2 revealed paresthesias in the face that were very transient. They involved the right hand and face and at 3 V but resolved in less than 5 seconds. There were no adverse effects with monopolar stimulation through Contacts 1 and 3. At this point the patient had a very good microlesioning effect and therefore there was not much tremor improvement to be seen. With this excellent result, the left Vim DBS lead was secured in place ( Fig. 2) . At this juncture the patient expressed significant fatigue and requested that the procedure be stopped. The patient also exhibited refractory hypertension during the case and the decision was made to stage the procedure.
The patient returned for follow-up placement of her left infraclavicular pulse generator 1 week later, and she underwent implantation of her contralateral right DBS lead 2 weeks after her initial procedure. The right Vim nucleus was targeted 12 mm lateral to the AC-PC line and 6 mm posterior to the midpoint of the AC-PC line in an attempt to better target the medial Vim. Targets for both stimulator placements were chosen approximately 1-2 mm medial to the typical target for essential tremor to suppress voice tremor. The second DBS lead was implanted in a similar manner to the first, with confirmation of adequate control of voice, arm, and leg tremor prior to implantation of the electrode. However, this second procedure also included detailed intraoperative voice recordings and analysis before and after placement of the DBS lead to evaluate for improvement in vocal function (Tables 1 and 2 ). Finally, the patient underwent placement of her right infraclavicular pulse generator 1 week later. The patient tolerated all procedures without difficulty or immediate complications. Postoperatively, from each DBS procedure, the patient experienced a persistent microlesioning effect with improvement in both extremity and voice tremor such that she was able to discontinue her medications. The patient underwent programming of her bilateral Vim DBS lead 2 weeks later with standard programming protocols to optimize extremity tremor reduction. Contact 2-was selected and programmed to an amplitude of 2.0 V bilaterally with excellent response in both extremity and vocal tremor. Vocal tremor data were acquired intraoperatively during implantation of the patient's DBS leads and during the initial programming visit after bilateral lead placement was complete. Unfortunately, due to technical difficulties, intraoperative voice tremor data for the initial DBS implantation were not of high enough quality for analysis; thus, no conclusions about the laterality of treatment effects can be drawn. All measures of vocal tremor were taken at the point of optimally suppressed extremity tremor. Specifically, audio recordings of sustained vowel production were collected from the patient at a sampling rate of 50,000 Hz. Vowel productions were collected in stimulation-off and stimulation-on conditions. Representative sustained productions of the vowels /a/ and /i/ were analyzed using the Praat Speech Analysis Program. A middle 2-second portion of the vowel produced by the patient at a comfortable pitch and loudness was used for analysis. Acoustical analyses of tremor characteristics included determination of rate of F0 and intensity modulation and average extent of F0 and intensity modulation. Vowels were also analyzed for voice breaks, jitter, and shimmer. Data collected intraoperatively are displayed in Tables 1  and 2 while data collected at the programming visit are displayed in Tables 3 and 4 . During the intraoperative visit reductions in the rate and average extent of F0 and intensity modulation was observed for both vowel productions in the stimulation-on and compared with the stimulationoff condition. No evident changes were observed in voicing, jitter, and shimmer. During the programming visit, the rate of F0 and intensity modulation remained consistent in the stimulation-on and stimulation-off conditions for both /i/ and /a/ vowel productions. However, reductions in the average extent of F0 and intensity modulations were observed for both vowel productions in the stimulation-on condition. In addition, for the /a/ vowel production we observed a reduction in the number of voice breaks and fraction of unvoiced frames as well as in jitter. Perceptually, these findings correlated with a less audible vocal tremor both intraoperatively and at the programming visit. The voice assessment procedures used for this investigation require only a microphone, a laptop, and acoustic software freely available online. These procedures can be readily applied by speech language pathology and otolaryngology professionals to assess EVT during DBS implantation surgery.
discussion
Here, we report the successful treatment of EVT using awake, frameless DBS guided by intraoperative voice analysis. We used specific Vim neurophysiological targets and real-time feedback in the operating room to modulate speech, and we produced successful control of vocal tremor without diminishing any DBS treatment effect of concurrent extremity tremor. Further study is necessary to determine optimal target locations to simultaneously address multiple tremor types that may commonly occur together. Long-term follow-up is also needed to validate these clinical results.
Our case report represents a proof of concept and highlights the ongoing need for further studies and larger clinical trials of DBS in vocal tremor. EVT is only one indication for DBS. Our multidisciplinary approach with rigorous preoperative, intraoperative, and postoperative voice testing can be expanded for other voice disorders including those related to PD and dystonia.
pd-related voice disorders
PD-related voice disorders affect between 70% and 90% of PD patients and manifest as hypokinetic dysarthrophonia, which is characterized by alterations in verbal communication, including hoarse voice, hypophonia, slurring together of syllables, and speech hesitation. 38 While many studies exist in the literature reporting improvement in specific parameters of vocal measures in PD patients following STN DBS, 5, 6, 9, 10, 20, 33, 41 stimulation-related dysarthria is also experienced in nearly 10% of PD patients with STN DBS. 19 Closer study of the somatotopy of the STN from primate anatomical studies reveal spatial distinctions between cells responding to orofacial movements (dorsal and rostrally located) versus those responding to limb (arm more lateral and leg more medial) movements. 47 In fact, dual inputs exist from both primary motor cortex as well as the supplementary motor area that are somatotopically mirrored within the STN with limb inputs occurring in central zones in a mediolateral distribution and orofacial inputs along the dorsal/rostral and most mediolateral extents of the STN. 30 Determination of optimal stimulus locations for specific PD voice-related symptoms with STN DBS is likely related to this somatotopic organization of the STN, and treatment of limb-related movement disorder versus other manifestations of PD (such as orofacial, dysarthrophonia, and head/neck rigidity symptoms) will likely depend on more precise electrode placement with this organization.
spasmodic dysphonia
Spasmodic dysphonias are the most common subset of the laryngeal dystonias; 17 90% of these focal, action-specific laryngeal muscle spasms involve the adductor muscle. Electromyography-guided thyroarytenoid botulinum A toxin injection is the current standard of treatment but is plagued by loss of phonatory volume, dysphagia, and need for repeat injections every 3 months. 34 Efficacy of botulinum A toxin treatment of abductor spasmodic dysphonia is more variable than the adductor variety. DBS already plays a prominent role in the treatment of primary generalized dystonia with validated targets in the internal glo- 31 and may represent a promising therapeutic avenue for the spasmodic dysphonias. A suitable target has not yet been identified; however, 1 report of DBS for DYT6 dystonia using the thalamic ventral lateral anterior nucleus (after failure at globus pallidus pars interna) demonstrated a significant improvement in spasmodic dysphonia symptoms. 29 conclusions DBS has been discussed for approximately 15 years as a potential therapeutic modality for patients with EVT. However, to date, very few studies can be identified that have sought to systematically examine improvements in EVT following DBS surgery. EVT assessments in these studies are typically not comprehensive (e.g., they include direct laryngeal visualization and instrumental voice measures) and are inconsistent with time points used for data collection. Despite these limitations, studies do demonstrate positive findings, including reductions in the rate of F0 modulation and overall tremor severity. Consequently, we are in critical need of investigations that seek to systematically and prospectively determine the effectiveness of DBS as an intervention for EVT. These studies should include comprehensive laryngeal and voice assessment pre-, intra-, and postoperatively. Furthermore, comprehensive laryngeal and voice assessment should incorporate nasal endoscopy for direct laryngeal visualization and instrumental voice assessments including acoustics and aerodynamics, as well as perceptual analyses of voice by both the patient and clinicians. Comprehensive assessment of EVT prior to, during, and following DBS surgery will assist in the development of evidence-based guidelines regarding DBS as an effective intervention for vocal tremor. Findings have the potential to alter treatment paradigms for these difficult-to-serve patients.
